Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Infectious Diseases Molecular Diagnostics Kit Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Diseases Molecular Diagnostics Kit Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Diseases Molecular Diagnostics Kit Overall Market Size
2.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size: 2021 VS 2028
2.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Infectious Diseases Molecular Diagnostics Kit Players in Global Market
3.2 Top Global Infectious Diseases Molecular Diagnostics Kit Companies Ranked by Revenue
3.3 Global Infectious Diseases Molecular Diagnostics Kit Revenue by Companies
3.4 Top 3 and Top 5 Infectious Diseases Molecular Diagnostics Kit Companies in Global Market, by Revenue in 2021
3.5 Global Companies Infectious Diseases Molecular Diagnostics Kit Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Kit Players in Global Market
3.6.1 List of Global Tier 1 Infectious Diseases Molecular Diagnostics Kit Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Kit Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Infectious Diseases Molecular Diagnostics Kit Market Size Markets, 2021 & 2028
4.1.2 Polymerase Chain Reaction PCR
4.1.3 Molecular Hybridization
4.1.4 Biochip
4.1.5 Other
4.2 By Type - Global Infectious Diseases Molecular Diagnostics Kit Revenue & Forecasts
4.2.1 By Type - Global Infectious Diseases Molecular Diagnostics Kit Revenue, 2017-2022
4.2.2 By Type - Global Infectious Diseases Molecular Diagnostics Kit Revenue, 2023-2028
4.2.3 By Type - Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infectious Diseases Molecular Diagnostics Kit Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Third-party Testing Agency
5.1.4 Other
5.2 By Application - Global Infectious Diseases Molecular Diagnostics Kit Revenue & Forecasts
5.2.1 By Application - Global Infectious Diseases Molecular Diagnostics Kit Revenue, 2017-2022
5.2.2 By Application - Global Infectious Diseases Molecular Diagnostics Kit Revenue, 2023-2028
5.2.3 By Application - Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Infectious Diseases Molecular Diagnostics Kit Market Size, 2021 & 2028
6.2 By Region - Global Infectious Diseases Molecular Diagnostics Kit Revenue & Forecasts
6.2.1 By Region - Global Infectious Diseases Molecular Diagnostics Kit Revenue, 2017-2022
6.2.2 By Region - Global Infectious Diseases Molecular Diagnostics Kit Revenue, 2023-2028
6.2.3 By Region - Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Infectious Diseases Molecular Diagnostics Kit Revenue, 2017-2028
6.3.2 US Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.3.3 Canada Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.3.4 Mexico Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Infectious Diseases Molecular Diagnostics Kit Revenue, 2017-2028
6.4.2 Germany Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.4.3 France Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.4.4 U.K. Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.4.5 Italy Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.4.6 Russia Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.4.7 Nordic Countries Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.4.8 Benelux Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Infectious Diseases Molecular Diagnostics Kit Revenue, 2017-2028
6.5.2 China Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.5.3 Japan Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.5.4 South Korea Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.5.5 Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.5.6 India Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Infectious Diseases Molecular Diagnostics Kit Revenue, 2017-2028
6.6.2 Brazil Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.6.3 Argentina Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Revenue, 2017-2028
6.7.2 Turkey Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.7.3 Israel Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.7.4 Saudi Arabia Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
6.7.5 UAE Infectious Diseases Molecular Diagnostics Kit Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.1.4 Roche Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Qiagen
7.2.1 Qiagen Corporate Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.2.4 Qiagen Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.2.5 Qiagen Key News
7.3 Illumina
7.3.1 Illumina Corporate Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.3.4 Illumina Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.3.5 Illumina Key News
7.4 Abbott
7.4.1 Abbott Corporate Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.4.4 Abbott Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.4.5 Abbott Key News
7.5 Hologic
7.5.1 Hologic Corporate Summary
7.5.2 Hologic Business Overview
7.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.5.4 Hologic Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.5.5 Hologic Key News
7.6 BioMerieux
7.6.1 BioMerieux Corporate Summary
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.6.4 BioMerieux Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.6.5 BioMerieux Key News
7.7 Danaher (Cepheid)
7.7.1 Danaher (Cepheid) Corporate Summary
7.7.2 Danaher (Cepheid) Business Overview
7.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.7.4 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.7.5 Danaher (Cepheid) Key News
7.8 Myriad Genetics
7.8.1 Myriad Genetics Corporate Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.8.4 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.8.5 Myriad Genetics Key News
7.9 DAAN Gene
7.9.1 DAAN Gene Corporate Summary
7.9.2 DAAN Gene Business Overview
7.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.9.4 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.9.5 DAAN Gene Key News
7.10 Agilent
7.10.1 Agilent Corporate Summary
7.10.2 Agilent Business Overview
7.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.10.4 Agilent Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.10.5 Agilent Key News
7.11 Genomic Health
7.11.1 Genomic Health Corporate Summary
7.11.2 Genomic Health Business Overview
7.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.11.4 Genomic Health Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.11.5 Genomic Health Key News
7.12 BD
7.12.1 BD Corporate Summary
7.12.2 BD Business Overview
7.12.3 BD Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.12.4 BD Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.12.5 BD Key News
7.13 Foundation Medicine
7.13.1 Foundation Medicine Corporate Summary
7.13.2 Foundation Medicine Business Overview
7.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Major Product Offerings
7.13.4 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Revenue in Global Market (2017-2022)
7.13.5 Foundation Medicine Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer